SGC-0946 | m-entrepreneurship.com

Product Name :
SGC-0946

Search keywords :
SGC0946

drugId :
null

Target Vo:
DOT1 like histone lysine methyltransferase

Target Vo Short Name :
DOT1L

Moa_Name:
DOT1 like histone lysine methyltransferase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Toronto, Toronto

Active Company_Name :
University Of Toronto, Toronto

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-c-Met (Tyr1349) Antibody
ATF4 Antibody
CEA Antibody (YA917): CEA Antibody (YA917) is an unconjugated, approximately 150-200 kDa, mouse-derived, anti-CEA (YA917) monoclonal antibody. CEA Antibody (YA917) can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, background without labeling.

Author: Betaine hydrochloride

Related Posts